<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3AElderly_adult_meningitis_antibiotics</id>
	<title>Template:Elderly adult meningitis antibiotics - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3AElderly_adult_meningitis_antibiotics"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Elderly_adult_meningitis_antibiotics&amp;action=history"/>
	<updated>2026-04-19T18:23:12Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Elderly_adult_meningitis_antibiotics&amp;diff=386425&amp;oldid=prev</id>
		<title>Danbot: Convert to AntibioticDose with disease=Meningitis</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Elderly_adult_meningitis_antibiotics&amp;diff=386425&amp;oldid=prev"/>
		<updated>2026-03-20T00:57:50Z</updated>

		<summary type="html">&lt;p&gt;Convert to AntibioticDose with disease=Meningitis&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 00:57, 20 March 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/del&gt;Ceftriaxone&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]] &lt;/del&gt;2gm (50mg/kg) IV BID daily '''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{AntibioticDose|disease=Meningitis|drug=&lt;/ins&gt;Ceftriaxone&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|dose=&lt;/ins&gt;2gm (50mg/kg) IV BID daily&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|context=Adult &amp;gt;50yr/Immunocompromised}} &lt;/ins&gt;'''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/del&gt;Vancomycin&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]] &lt;/del&gt;15-20 mg/kg IV BID daily '''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{AntibioticDose|disease=Meningitis|drug=&lt;/ins&gt;Vancomycin&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|dose=&lt;/ins&gt;15-20 mg/kg IV BID daily&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|context=Adult &amp;gt;50yr/Immunocompromised}} &lt;/ins&gt;'''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/del&gt;Ampicillin&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]] &lt;/del&gt;2gm IV q4h (hourly if listeria suspected)&amp;lt;ref&amp;gt;[Guideline] Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul. 15(7):649-59.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{AntibioticDose|disease=Meningitis|drug=&lt;/ins&gt;Ampicillin&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|dose=&lt;/ins&gt;2gm IV q4h (hourly if listeria suspected)&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|context=Adult &amp;gt;50yr/Immunocompromised}}&lt;/ins&gt;&amp;lt;ref&amp;gt;[Guideline] Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul. 15(7):649-59.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Elderly_adult_meningitis_antibiotics&amp;diff=41744&amp;oldid=prev</id>
		<title>Ostermayer at 17:30, 5 July 2015</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Elderly_adult_meningitis_antibiotics&amp;diff=41744&amp;oldid=prev"/>
		<updated>2015-07-05T17:30:20Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 17:30, 5 July 2015&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*[[Ceftriaxone]] 2gm (50mg/kg) IV BID daily '''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*[[Ceftriaxone]] 2gm (50mg/kg) IV BID daily '''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*[[Vancomycin]] 15-20 mg/kg IV BID daily '''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*[[Vancomycin]] 15-20 mg/kg IV BID daily '''PLUS'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Ampicillin &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2 g &lt;/del&gt;q4h (hourly if listeria suspected)&amp;lt;ref&amp;gt;[Guideline] Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul. 15(7):649-59.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/ins&gt;Ampicillin&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]] 2gm IV &lt;/ins&gt;q4h (hourly if listeria suspected)&amp;lt;ref&amp;gt;[Guideline] Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul. 15(7):649-59.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Elderly_adult_meningitis_antibiotics&amp;diff=41741&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;*Ceftriaxone 2gm (50mg/kg) IV BID daily '''PLUS''' *Vancomycin 15-20 mg/kg IV BID daily '''PLUS''' *Ampicillin 2 g q4h (hourly if listeria suspected)&lt;ref&gt;[Guideline] C...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Elderly_adult_meningitis_antibiotics&amp;diff=41741&amp;oldid=prev"/>
		<updated>2015-07-05T17:27:39Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;*&lt;a href=&quot;/wiki/Ceftriaxone&quot; title=&quot;Ceftriaxone&quot;&gt;Ceftriaxone&lt;/a&gt; 2gm (50mg/kg) IV BID daily &amp;#039;&amp;#039;&amp;#039;PLUS&amp;#039;&amp;#039;&amp;#039; *&lt;a href=&quot;/wiki/Vancomycin&quot; title=&quot;Vancomycin&quot;&gt;Vancomycin&lt;/a&gt; 15-20 mg/kg IV BID daily &amp;#039;&amp;#039;&amp;#039;PLUS&amp;#039;&amp;#039;&amp;#039; *Ampicillin 2 g q4h (hourly if listeria suspected)&amp;lt;ref&amp;gt;[Guideline] C...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;*[[Ceftriaxone]] 2gm (50mg/kg) IV BID daily '''PLUS'''&lt;br /&gt;
*[[Vancomycin]] 15-20 mg/kg IV BID daily '''PLUS'''&lt;br /&gt;
*Ampicillin 2 g q4h (hourly if listeria suspected)&amp;lt;ref&amp;gt;[Guideline] Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul. 15(7):649-59.&amp;lt;/ref&amp;gt;&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>